The absence of invariant chain in MHC II cancer vaccines enhances the activation of tumor-reactive type 1 CD4(+) T lymphocytes

Podobne zapisy

• Lung cancer patients’ CD4(+) T cells are activated in vitro by MHC II cell-based vaccines despite the presence of myeloid-derived suppressor cells
  od: Srivastava, Minu K., i wsp.
  Wydane: (2008)
• Uveal melanoma cell-based vaccines express MHC II molecules that traffic via the endocytic and secretory pathways and activate CD8(+) cytotoxic, tumor-specific T cells
  od: Bosch, Jacobus J., i wsp.
  Wydane: (2009)
• MHC II Lung Cancer Vaccines Prime and Boost Tumor-specific CD4(+) T Cells that Cross-React with Multiple Histologic Subtypes of Non-small Cell Lung Cancer Cells
  od: Srivastava, Minu K., i wsp.
  Wydane: (2010)
• Myeloid-derived Suppressor Cells Inhibit T Cell Activation by Depleting Cystine and Cysteine
  od: Srivastava, Minu K., i wsp.
  Wydane: (2009)
• Association with BiP and aggregation of class II MHC molecules synthesized in the absence of invariant chain.
  od: Bonnerot, C, i wsp.
  Wydane: (1994)